Product
OPA-15406 Ointment
Aliases
0.3% OPA-15406 Ointment
1 clinical trial
1 indication
Indication
Atopic DermatitisClinical trial
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Clinical Trial to Demonstrate the Superiority of 0.3% and 1% OPA-15406 Ointment Versus Vehicle in Pediatric Subjects With Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-11-30